Susquehanna International Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Susquehanna International Group’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-176,051	Closed	-$3.16M	–	10823
2017 Q4	$3.16M	Buy	+176,051	New	+$2.17M	﹤0.01%	3153
2017 Q2	–	Sell	-38,700	Closed	-$394K	–	10286
2017 Q1	$426K	Sell	38,700 -59,220	-60%	-$687K	﹤0.01%	6776
2016 Q4	$1.33M	Buy	97,920 +34,542	+55%	+$482K	﹤0.01%	4928
2016 Q3	$780K	Sell	63,378 -39,021	-38%	-$460K	﹤0.01%	5267
2016 Q2	$1.12M	Buy	102,399 +86,557	+546%	+$969K	﹤0.01%	4641
2016 Q1	$173K	Sell	15,842 -92,396	-85%	-$1.17M	﹤0.01%	8094
2015 Q4	$1.87M	Sell	108,238 -106,439	-50%	-$1.91M	﹤0.01%	4164
2015 Q3	$4.26M	Buy	214,677 +35,770	+20%	+$820K	﹤0.01%	2913
2015 Q2	$2.94M	Buy	178,907 +63,050	+54%	+$1.09M	﹤0.01%	3895
2015 Q1	$1.8M	Buy	115,857 +98,657	+574%	+$1.53M	﹤0.01%	4513
2014 Q4	$246K	Buy	+17,200	New	+$182K	﹤0.01%	8475

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Susquehanna International Group's SCMP Position: Q1 2018 in Review

Susquehanna International Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 176,051 shares — an estimated $3.16M sold.

Susquehanna International Group first reported a position in SCMP in Q4 2014 and held it in 11 quarters. The position peaked at $4.26M in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Susquehanna International Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Susquehanna International Group sold 176,051 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $3.16M.
Susquehanna International Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 11 quarters.
Susquehanna International Group's Sucampo Pharmaceuticals, Inc. position peaked at $4.26M in Q3 2015.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.